Skip to main content
Kangmei Pharmaceutical Co.,Ltd logo

Kangmei Pharmaceutical Co.,Ltd — Investor Relations & Filings

Ticker · 600518 ISIN · CNE0000017M1 LEI · 3003006FRNBUUTVKBB50 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,369 across all filing types
Latest filing 2025-04-18 Annual Report
Country CN China
Listing Shanghai Stock Exchange 600518

About Kangmei Pharmaceutical Co.,Ltd

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co.,Ltd. focuses on the research, development, production, and distribution of Traditional Chinese Medicine (TCM). The company manages an integrated industry chain that includes herbal cultivation, standardized processing of decoction pieces, and the manufacturing of patent medicines. Its offerings extend to health supplements, medical devices, and functional foods. A key component of its operations is the management of large-scale TCM trading centers and logistics hubs designed to standardize the trade of medicinal materials. Through its "Internet + Healthcare" initiatives, the company provides digital health management and pharmaceutical supply chain services, catering to medical institutions, retail pharmacies, and individual consumers.

Recent filings

Filing Released Lang Actions
康美药业2024年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2024 年年度报告摘要" which translates to "2024 Annual Report Summary". It contains detailed financial data for the year 2024, including total assets, net profit, revenue, and quarterly breakdowns. It also includes company business descriptions, industry overview, shareholder information, and audit opinions. The presence of a standard unqualified audit report from an accounting firm is mentioned, which is typical in annual reports. The document length is 8885 characters, which is substantial and contains actual financial data and analysis, not just an announcement or summary notice. Therefore, this document is the actual Annual Report (10-K equivalent) or a summary thereof, but given the detailed financial data and comprehensive business overview, it fits best under the Annual Report category (10-K). FY 2024
2025-04-18 Chinese
中审众环会计师事务所（特殊普通合伙）关于康美药业内部控制审计报告（2024）
Regulatory Filings
2025-04-18 Chinese
康美药业关于召开2024年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2024 Annual General Meeting (AGM) of 康美药业股份有限公司, including details such as the date, voting methods, meeting agenda, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather informs shareholders about the meeting and the matters to be discussed and voted on. The document length is 3633 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-18 Chinese
康美药业2024年度独立董事述职报告（曾庆）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2024 by an independent director of 康美药业股份有限公司. It details the director's qualifications, attendance at board and committee meetings, communication with auditors, oversight of financial reporting, and other governance-related activities during the year. The content focuses on the director's duties, compliance with laws and regulations, and evaluation of company governance and financial reporting processes. It does not contain financial statements or detailed financial data itself, but rather a narrative report on the director's activities and observations. This type of document is a report by a board member on their management and governance role, which fits best under the category of Board/Management Information (MANG). The document length is about 4054 characters, which is consistent with a detailed narrative report rather than a full annual report or audit report. Therefore, the classification is MANG with high confidence.
2025-04-18 Chinese
康美药业2024年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "Board Audit Committee 2024 Annual Performance Report" from 康美药业股份有限公司 (Kangmei Pharmaceutical Co., Ltd.). It details the audit committee's activities, meetings, supervision of external and internal audits, review of financial reports, internal control evaluations, and related governance matters for the year 2024. The content focuses on the audit committee's oversight and reporting duties rather than presenting full financial statements or audit opinions themselves. The document length is 4044 characters, which is relatively short and reads like a committee report rather than a full audit report or annual report. It is not a certification or a brief announcement but a detailed committee report on audit-related activities. This fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and results of internal or regulatory audits excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2024
2025-04-18 Chinese
康美药业2024年度独立董事述职报告（赖小平）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2024 by an independent director of 康美药业股份有限公司. It details the director's duties, attendance at board and committee meetings, communication with auditors and shareholders, and oversight activities during the year. It includes no financial statements or substantive financial data but focuses on governance, compliance, and director activities. The document length is 4322 characters, which is relatively short and reads like a formal report by a board member rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed narrative on the independent director's role and activities. This fits best under Board/Management Information (MANG), which covers announcements of changes or reports related to board or senior management activities. Therefore, the classification is MANG with high confidence.
2025-04-18 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.